CNBC's Jim Cramer explains how the market's overreaction in late 2018 has investors feeling a sense of certainty in the new year. The "Mad Money" host also checks in with the CEOs of Kirkland Lake Gold and Appian Corp. In the lightning round, Cramer shares why he thinks GW Pharmaceuticals' stock can go higher.
U.S. investors seem to be willing to accept a bad trade deal with China if it means getting back to "business as usual," says CNBC's Jim Cramer. It hardly matters, though, because stocks have more upside than downside here, Cramer says. The stock market's positive response to a report that U.S. officials were considering lifting tariffs on China to get a trade deal was telling, but it wasn't necessarily good, CNBC's Jim Cramer said Thursday.
CNBC's Jim Cramer reflects on how the late Jack Bogle changed the industry.
Jim Cramer explains why there's been more merger and acquisition activity in recent months and says it's "just getting started."